V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001528 | 230011012 | null | null | Adjuvant (A) | 2020-01-24 | 2020-03-27 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100311026 |
| 230001540 | 230011014 | null | null | null | 2018-07-26 | 2018-08-02 | null | null | null | CISPLATIN | 100852176 |
| 230001549 | 230011015 | 1.67 | 106.2 | null | 2020-07-05 | 2020-07-21 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100038890 |
| 230001567 | 230011019 | 1.63 | 105.55 | Adjuvant (A) | 2021-11-26 | 2022-04-03 | ICON8B TRIAL | 02 | null | CAPECITABINE + OXALIPLATIN | 101215167 |
| 230001568 | 230011020 | 1.6 | 74.7 | null | 2020-08-12 | 2020-08-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100179612 |
| 230001588 | 230011022 | 1.64 | 68.3 | null | 2020-01-14 | 2020-02-26 | null | 01 | null | GEMCITABINE | 100263283 |
| 230001589 | 230011023 | 1.74 | 83 | null | null | 2018-10-31 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100729650 |
| 230001590 | 230011024 | 1.64 | 71.9 | null | 2020-12-30 | 2021-01-12 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100381159 |
| 230001597 | 230011025 | 1.67 | 49.5 | null | 2020-03-13 | 2020-03-17 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101314662 |
| 230001620 | 230011027 | 1.54 | 71 | null | 2022-02-12 | 2022-03-19 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100388675 |
| 230001648 | 230011029 | null | null | null | 2020-04-18 | 2020-06-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100807166 |
| 230001653 | 230011030 | 1.67 | 118.5 | Adjuvant (A) | 2019-02-27 | 2019-04-09 | Cisplatin | 02 | null | CISPLATIN | 101812817 |
| 230001654 | 230011031 | 1.64 | 62.7 | null | 2022-04-24 | 2022-04-24 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100223869 |
| 230001688 | 230011035 | null | null | null | null | 2020-10-25 | null | 01 | null | NIVOLUMAB | 100411615 |
| 230001697 | 230011038 | 1.7 | 55.6 | null | null | 2018-10-09 | null | N | null | CARBOPLATIN + GEMCITABINE | 100546781 |
| 230001701 | 230011039 | 1.68 | 49.65 | null | 2020-06-24 | 2020-11-17 | null | null | null | BEVACIZUMAB | 100154763 |
| 230001706 | 230011040 | 1.74 | 66.55 | null | 2017-12-18 | 2017-12-28 | null | N | null | BEVACIZUMAB | 100983724 |
| 230001712 | 230011041 | 1.54 | 77.5 | null | 2020-03-12 | 2020-04-03 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100945253 |
| 230001716 | 230011043 | 1.55 | 72.4 | Palliative (P) | 2020-08-18 | 2020-09-03 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100797083 |
| 230001720 | 230011044 | 1.57 | 114 | Adjuvant (A) | 2022-03-20 | 2022-05-16 | null | 02 | N | TRIAL UNSPECIFIED | 100401581 |
| 230001774 | 230011050 | 1.6 | 56.6 | Neo-adjuvant (N) | 2021-03-09 | 2021-03-24 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101164593 |
| 230001809 | 230011053 | 1.51 | 63.7 | null | 2020-10-11 | 2020-10-13 | Niraparib | 02 | null | NIRAPARIB | 100132664 |
| 230001810 | 230011054 | 1.7 | 83 | null | 2018-07-26 | 2018-08-05 | null | 02 | null | TRIAL UNSPECIFIED | 101108378 |
| 230001815 | 230011056 | 1.58 | 64.5 | null | 2020-12-06 | 2020-12-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101779065 |
| 230001817 | 230011057 | 1.64 | 59.2 | null | null | 2021-11-04 | Cisplatin | 02 | null | CISPLATIN | 100834006 |
| 230001819 | 230011058 | 1.62 | 96.6 | null | 2022-01-26 | 2022-01-31 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101032091 |
| 230001848 | 230011060 | 1.47 | null | null | 2021-08-26 | 2022-04-06 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101558616 |
| 230001886 | 230011064 | 1.53 | 78.7 | null | 2018-09-04 | 2018-09-09 | Bevacizumab | 02 | null | BEVACIZUMAB | 100798503 |
| 230001890 | 230011065 | 1.48 | 52.5 | null | 2022-03-09 | 2022-04-06 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101429851 |
| 230001925 | 230011068 | 1.53 | 81 | null | null | 2022-02-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100276572 |
| 230001941 | 230011072 | null | 65 | null | 2021-06-17 | 2021-07-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100644877 |
| 230001955 | 230011076 | 1.7 | 79.3 | null | 2018-01-07 | 2021-05-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100203421 |
| 230001959 | 230011077 | 1.61 | 57.6 | null | 2021-10-22 | 2021-10-22 | Carboplatin + Docetaxel | 02 | null | PEMBROLIZUMAB | 100633551 |
| 230001966 | 230011078 | 1.62 | 85.6 | null | 2021-07-17 | 2021-11-12 | ICON8B TRIAL | 02 | null | NAB-PACLITAXEL | 101170545 |
| 230001982 | 230011081 | 1.65 | 41 | null | null | 2018-08-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101163629 |
| 230001986 | 230011082 | 1.65 | 61 | null | 2021-05-20 | 2021-05-25 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101362307 |
| 230002049 | 230011085 | 1.51 | null | null | 2019-02-26 | 2019-10-11 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101426792 |
| 230002050 | 230011086 | 1.54 | 54.1 | null | null | 2019-11-22 | Niraparib | 02 | null | NIRAPARIB | 101559296 |
| 230002074 | 230011088 | null | null | null | 2021-09-12 | 2021-12-23 | null | null | null | FLUOROURACIL + OXALIPLATIN | 100788758 |
| 230002078 | 230011090 | 1.78 | 50.6 | null | 2021-04-07 | 2021-04-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101221344 |
| 230002089 | 230011091 | null | null | Palliative (P) | 2018-11-23 | 2021-05-23 | Doxorubicin 75mg/m2 | 02 | N | GEMCITABINE | 101402009 |
| 230002096 | 230011092 | 1.55 | 99 | Palliative (P) | 2021-07-24 | 2021-07-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100069176 |
| 230002117 | 230011096 | 1.66 | 74.6 | Neo-adjuvant (N) | 2021-12-10 | 2021-12-16 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + DOXORUBICIN | 100477391 |
| 230002124 | 230011098 | 1.47 | 62.8 | Palliative (P) | null | 2020-08-10 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100318201 |
| 230002139 | 230011100 | 1.56 | 80.5 | null | null | 2020-10-21 | Olaparib | 02 | null | OLAPARIB | 100761734 |
| 230002144 | 230011101 | null | null | null | null | 2021-05-09 | null | 02 | null | DICE TRIAL | 100159162 |
| 230002148 | 230011103 | 1.59 | 56.5 | Palliative (P) | 2022-01-28 | 2022-02-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101606687 |
| 230002164 | 230011104 | 1.6 | 70.7 | Palliative (P) | 2019-10-16 | 2021-08-08 | CARBOPLATIN + GEMCITABINE | 02 | Y | CARBOPLATIN + GEMCITABINE | 100317806 |
| 230002179 | 230011105 | 1.67 | 92.85 | null | null | 2021-12-18 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100556662 |
| 230002213 | 230011107 | 1.63 | 61.8 | null | 2021-08-17 | 2021-11-20 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100396177 |